Results 291 to 300 of about 3,286,390 (370)
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane+16 more
wiley +1 more source
Prolonged Cytopenia with CAR-T Cell Therapy and Management Recommendations. [PDF]
Dahunsi D+3 more
europepmc +1 more source
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma [PDF]
Bartlett, N. L, et al,, Ghobadi, A.
core +1 more source
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer
We used whole exome and RNA‐sequencing to profile divergent genomic and transcriptomic landscapes of microsatellite stable (MSS) and microsatellite instable (MSI) colorectal cancer. Alterations were classified using a computational score for integrative cancer variant annotation and prioritization.
Efstathios‐Iason Vlachavas+15 more
wiley +1 more source
CAR-T cells in the treatment of multiple myeloma: an encouraging cell therapy. [PDF]
Yu T, Jiao JH, Wu MF.
europepmc +1 more source
Mathematical Modeling of the CAR T-cell Therapy [PDF]
Elliott, Samantha+2 more
core +1 more source
Cancer stem cells are associated with aggressive disease, but a deep characterization of such markers is lacking in endometrial cancer. This study uses imaging mass cytometry to explore putative cancer stem cell markers in endometrial tumors and corresponding organoid models.
Hilde E. Lien+7 more
wiley +1 more source
Influence of CAR T-cell therapy associated complications. [PDF]
Umair MM, Lai X, Xue Y, Yao H.
europepmc +1 more source
Pancreatic ductal adenocarcinoma patient‐derived xenografts (PDAC‐PDXs) engrafted orthotopically in the pancreas of immunodeficient mice retain the main genetic and histopathological characteristics of the original human tumors. A 294 stroma gene signature differentiates between PDAC‐PDXs that are responsive to gemcitabine plus nab‐paclitaxel versus ...
Alessia Anastasia+13 more
wiley +1 more source